Cellectar Biosciences, Inc. (NASDAQ: CLRB) announces a 1-for-10 reverse stock split of its common stock, effective at the close of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE